Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara. [electronic resource]

By: Contributor(s): Producer: 20170612Description: 442 p. digitalISSN:
  • 1475-2875
Subject(s): Online resources: In: Malaria journal vol. 15
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial

There are no comments on this title.

to post a comment.